Microvascular obstruction in patients with non-ST-elevation myocardial infarction: A contrast-enhanced cardiac magnetic resonance study

International Journal of Cardiovascular Imaging

Volumn 30, Issue 6, 2014, Pages 1087-1095

  Guerra, Elena ^a   Hadamitzky, Martin ^a   Ndrepepa, Gjin ^a   Bauer, Corinna ^a   Ibrahim, Tareq ^b   Ott, Ilka ^a   Laugwitz, Karl Ludwig ^b,c   Schunkert, Heribert ^a,c   Kastrati, Adnan ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Cardiac magnetic resonance imaging; Microvascular obstruction; No reflow; Non ST elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; TROPONIN T; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR MAGNETIC RESONANCE; COLLATERAL CIRCULATION; CONTRAST ENHANCEMENT; CORONARY ARTERY CIRCUMFLEX BRANCH; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MICROVASCULAR OBSTRUCTION; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE SCANNER; PERCUTANEOUS CORONARY INTERVENTION; THROMBOLYSIS IN MYOCARDIAL INFARCTION; ADVERSE EFFECTS; BLOOD; CHI SQUARE DISTRIBUTION; CORONARY ARTERY BLOOD FLOW; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; NUCLEAR MAGNETIC RESONANCE IMAGING; ODDS RATIO; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

AGED; BIOMARKERS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CREATINE KINASE, MB FORM; FEMALE; GADOLINIUM DTPA; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T;

EID: 84904558904     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-014-0430-z     Document Type: Article

References (54)

1. Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G et al (2005) Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 149:67-73 (Pubitemid 40126492)
2. Armstrong PW, Fu Y, Chang WC, Topol EJ, Granger CB, Betriu A et al (1998) Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia: the GUSTO-IIb investigators. Circulation 98:1860-1868 (Pubitemid 28509281)
3. Ndrepepa G, Mehilli J, Schulz S, Iijima R, Keta D, Byrne RA et al (2009) Patterns of presentation and outcomes of patients with acute coronary syndromes. Cardiology 113:198-206
4. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J et al (1987) Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76:142-154 (Pubitemid 17093202)
5. Investigators G (2001) Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 141:190-199
6. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL et al (2000) Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT investigators. Circulation 101:2557-2567 (Pubitemid 30350632)
7. Ndrepepa G, Alger P, Fusaro M, Kufner S, Seyfarth M, Keta D et al (2011) Impact of perfusion restoration at epicardial and tissue levels on markers of myocardial necrosis and clinical outcome of patients with acute myocardial infarction. EuroIntervention 7:128-135
8. GUSTO Angiographic Investigators (1993) The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329:1615-1622
9. van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F, Zwolle Myocardial Infarction Study Group (1998) Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 97:2302-2306 (Pubitemid 28280383)
10. Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA et al (2010) 5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 55:2383-2389
11. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M et al (1996) Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 93:223-228 (Pubitemid 26031478)
12. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H et al (2000) Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36:1202-1209
13. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G et al (2004) Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 109:1121-1126 (Pubitemid 38332616)
14. Bogaert J, Kalantzi M, Rademakers FE, Dymarkowski S, Janssens S (2007) Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging. Eur Radiol 17:2572-2580
15. Husser O, Bodi V, Sanchis J, Nunez J, Lopez-Lereu MP, Monmeneu JV et al (2013) Predictors of cardiovascular magnetic resonance-derived microvascular obstruction on patient admission in STEMI. Int J Cardiol 166:77-84
16. Mewton N, Bonnefoy E, Revel D, Ovize M, Kirkorian G, Croisille P (2009) Presence and extent of cardiac magnetic resonance microvascular obstruction in reperfused non-ST-elevated myocardial infarction and correlation with infarct size and myocardial enzyme release. Cardiology 113:50-58
17. Plein S, Greenwood JP, Ridgway JP, Cranny G, Ball SG, Sivananthan MU (2004) Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol 44:2173-2181 (Pubitemid 39576037)
18. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP et al (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97:765-772 (Pubitemid 28135339)
19. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G (2006) Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol 47:1641-1645
20. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R (2008) The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 51:1581-1587 (Pubitemid 351508364)
21. Bondarenko O, Beek AM, Hofman MB, Kuhl HP, Twisk JW, van Dockum WG et al (2005) Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 7:481-485 (Pubitemid 40563339)
22. Hadamitzky M, Langhans B, Hausleiter J, Sonne C, Kastrati A, Martinoff S et al (2013) The assessment of area at risk and myocardial salvage after coronary revascularization in acute myocardial infarction: comparison between CMR and SPECT. JACC Cardiovasc Imaging 6:358-369
23. TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 312:932-936
24. Rentrop KP, Cohen M, Blanke H, Phillips RA (1985) Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5:587-592 (Pubitemid 15141963)
25. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ et al (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93:879-888 (Pubitemid 26074824)
26. Kerensky RA, Wade M, Deedwania P, Boden WE, Pepine CJ (2002) Veterans Affairs Non QWISi-HTI. Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol 39:1456-1463 (Pubitemid 34439060)
27. Sianos G, Papafaklis MI, Serruys PW (2010) Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol 22:6B-14B
28. Giannitsis E, Steen H, Kurz K, Ivandic B, Simon AC, Futterer S et al (2008) Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol 51:307-314
29. Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M, Kochs M et al (2005) Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 26:549-557 (Pubitemid 40461096)
30. Younger JF, Plein S, Barth J, Ridgway JP, Ball SG, Greenwood JP (2007) Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction. Heart 93:1547-1551 (Pubitemid 350205547)
31. Hombach V, Merkle N, Kestler HA, Torzewski J, Kochs M, Marx N et al (2008) Characterization of patients with acute chest pain using cardiac magnetic resonance imaging. Clin Res Cardiol 97:760-767
32. Van Assche L, Bekkers S, Senthilkumar A, parker MA, Kim AW, Kim RJ (2011) The prevalence of microvascular obstruction in acute myocardial infarction: importance of ST elevation, infarct size, transmurality and infarct age. J Cardiovasc Magn Reson 13(Suppl 1):P147
33. Kloner RA, Ganote CE, Jennings RB (1974) The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54:1496-1508
34. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD et al (1994) Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 89:2514-2518 (Pubitemid 24173664)
35. Erbel R, Heusch G (2000) Coronary microembolization. J Am Coll Cardiol 36:22-24 (Pubitemid 30466106)
36. Henriques JP, Zijlstra F, Van't Hof AW, de Boer MJ, Dambrink JH, Gosselink M et al (2003) Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 107:2115-2119 (Pubitemid 36532193)
37. Iwakura K, Ito H, Kawano S, Shintani Y, Yamamoto K, Kato A et al (2001) Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 38:472-477 (Pubitemid 32721776)
38. Lepper W, Hoffmann R, Kamp O, Franke A, de Cock CC, Kuhl HP et al (2000) Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty [correction of angiography] in patients with acute myocardial infarction. Circulation 101:2368-2374 (Pubitemid 30329126)
39. Schroder R, Dissmann R, Bruggemann T, Wegscheider K, Linderer T, Tebbe U et al (1994) Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 24:384-391 (Pubitemid 24246537)
40. Sorajja P, Gersh BJ, Costantini C, McLaughlin MG, Zimetbaum P, Cox DA et al (2005) Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. Eur Heart J 26:667-674 (Pubitemid 40516878)
41. Baks T, van Geuns RJ, Biagini E, Wielopolski P, Mollet NR, Cademartiri F et al (2005) Recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 26:1070-1077 (Pubitemid 40839907)
42. Nijveldt R, Beek AM, Hirsch A, Stoel MG, Hofman MB, Umans VA et al (2008) Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 52:181-189 (Pubitemid 351915778)
43. Porto I, Burzotta F, Brancati M, Trani C, Lombardo A, Romagnoli E et al (2007) Relation of myocardial blush grade to microvascular perfusion and myocardial infarct size after primary or rescue percutaneous coronary intervention. Am J Cardiol 99:1671-1673 (Pubitemid 46874311)
44. Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Sanz R, Palau P et al (2006) Microvascular perfusion 1 week and 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging. Heart 92:1801-1807 (Pubitemid 44851328)
45. Mather AN, Lockie T, Nagel E, Marber M, Perera D, Redwood S et al (2009) Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. J Cardiovasc Magn Reson 11:33
46. Wong DT, Leung MC, Richardson JD, Puri R, Bertaso AG, Williams K et al (2012) Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements. Int J Cardiovasc Imaging 28:1971-1981
47. Bekkers SC, Backes WH, Kim RJ, Snoep G, Gorgels AP, Passos VL et al (2009) Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging. Eur Radiol 19:2904-2912
48. Nijveldt R, Hofman MB, Hirsch A, Beek AM, Umans VA, Algra PR et al (2009) Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: cardiac MR imaging study. Radiology 250:363-370
49. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA (1995) Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: potential mechanisms. Circulation 92:1117-1125
50. Xu J, Song YB, Hahn JY, Chang SA, Lee SC, Choe YH et al (2012) Comparison of magnetic resonance imaging findings in non-ST-segment elevation versus ST-segment elevation myocardial infarction patients undergoing early invasive intervention. Int J Cardiovasc Imaging 28:1487-1497
51. Tzivoni D, Koukoui D, Guetta V, Novack L, Cowing G, Investigators CS (2008) Comparison of troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Am J Cardiol 101:753-757
52. Langhans B, Hendrich E, Schömig A, Martinoff S, Hadamitzky H (2013) Reproducibility of area at risk assessment in acute myocardial infarction by T1- and T2-mapping sequences in cardiac magnetic resonance imaging in comparison to Tc99 m-Sestamibi SPECT. J Cardiovasc Magn Reson 15:P240
53. Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK (2008) Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 1:415-423
54. Hallen J, Buser P, Schwitter J, Petzelbauer P, Geudelin B, Fagerland MW et al (2009) Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction. Am J Cardiol 104:1472-1477